Tricuspid Valve Reconstruction Using the Right Atrial Appendage
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 入组人数
- 30
- 试验地点
- 3
- 主要终点
- Mortality
研究概览
简要总结
we use part of the cardiac chambre for replacement of destroyed valve on right side of the heart
详细描述
Tricuspid Valve Reconstruction Using the Right Atrial Appendage by harvesting appropriate size then reconstruction as bileaflet valve after reinforcement of the annulus by pericardial band then the neovalve fixed to papillary muscles of the right ventricle by artificial chorda anchored by teflon pledgets
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •all patient need tricuspid valve replacement
排除标准
- •patient refusal
研究组 & 干预措施
right atrial appendage
right atrial appendage used for tricuspid valve reconstruction
干预措施: Tricuspid Valve Reconstruction (Procedure)
tissue valve
tissue valve used for tricuspid valve replacement
干预措施: tricuspid valve replacement (Procedure)
结局指标
主要结局
Mortality
时间窗: 30 day post operative
perioperative and short-term mortality, with no major procedure-related surgical complication
Morbidity
时间窗: 30 day post operative
measuring pressure gradient
时间窗: 6 months postoperative
Follow-up echocardiography by measuring pressure gradient across the neo valve
Thromboembolic Risk checklist
时间窗: 6 months postoperative
次要结局
未报告次要终点
研究者
Amr Elsayed Tawfek Ibrahim
assistant prof
Zagazig University